The Global Shoulder Concept (GSC) Method Versus Classic Physical Therapy for Shoulder Tendinitis

Sponsor
Centre Hospitalier Universitaire de Nīmes (Other)
Overall Status
Terminated
CT.gov ID
NCT01544244
Collaborator
(none)
40
2
2
43
20
0.5

Study Details

Study Description

Brief Summary

The primary objective of this study is to demonstrate the superiority of the CGE physical therapy protocol versus a standard physical therapy protocol of the shoulder by measuring the following after 1 month of physical therapy: the FI2S score including validated measures of pain, glenohumeral joint range of motion in the three planes, the ability to perform certain everyday activities and the strength of forward elevation measured with a dynamometer.

Condition or Disease Intervention/Treatment Phase
  • Procedure: GSC physical therapy
  • Procedure: Standard physical therapy
N/A

Detailed Description

Secondary objectives:
  • To study the evolution of passive glenohumeral range of motion

  • To study the evolution of the global range of passive and active motion for each method used

  • To evaluate functional recovery (DASH)

  • To evaluate the impact on quality of life (SF36)

  • To study the difference in visual analog scale scores for pain during physical therapy sessions

  • Compare the two methods/groups after three months.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of the Global Shoulder Concept (GSC) Method Versus Classic Physical Therapy for Shoulder Tendinitis: a Prospective, Randomized Study
Study Start Date :
Oct 1, 2012
Actual Primary Completion Date :
May 1, 2016
Actual Study Completion Date :
May 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: GSC physcial therapy

Patients included in this arm of the study will follow the Global Shoulder Concept physical therapy sequence.

Procedure: GSC physical therapy
Global Shoulder Concept physical therapy sequence for shoulder tendonitis. The procedures used in this protocol refer to physical therapy sequences, not to devices or drugs.

Active Comparator: Standard

Patients in this arm of the study will follow the standard physical therapy sequence.

Procedure: Standard physical therapy
Standard physical therapy sequence for shoulder tendonitis. The procedures used in this protocol refer to physical therapy sequences, not to devices or drugs.

Outcome Measures

Primary Outcome Measures

  1. change in FI2S score [90 days]

Secondary Outcome Measures

  1. Change in visual analog scale for pain [Day 1 versus baseline]

  2. Change in visual analog scale for pain [Day 5 versus baseline]

  3. Change in visual analog scale for pain [Day 12 versus baseline]

  4. Change in visual analog scale for pain [Day 19 versus baseline]

  5. Change in visual analog scale for pain [Day 26 versus baseline]

  6. Change in visual analog scale for pain [Day 90 versus baseline]

  7. Scapulohumeral amplitude gain in 3 main directions [Day 1]

    Passive and active mobility are evaluated by manual goniometry.

  8. Scapulohumeral amplitude gain in 3 main directions [Day 26]

    Passive and active mobility are evaluated by manual goniometry.

  9. Scapulohumeral amplitude gain in 3 main directions [Day 90]

    Passive and active mobility are evaluated by manual goniometry.

  10. Functional gain as measured by the DASH self questionnaire [Day 1]

  11. Functional gain as measured by the DASH self questionnaire [Day 5]

  12. Functional gain as measured by the DASH self questionnaire [Day 12]

  13. Functional gain as measured by the DASH self questionnaire [Day 19]

  14. Functional gain as measured by the DASH self questionnaire [Day 26]

  15. Functional gain as measured by the DASH self questionnaire [Day 90]

  16. FI2S score [Day 1]

  17. FI2S score [Day 5]

  18. FI2S score [Day 12]

  19. FI2S score [Day 19]

  20. FI2S score [Day 26]

  21. SF36 self questionnaire [Day 1]

  22. SF36 self questionnaire [Day 26]

  23. SF36 self questionnaire [Day 90]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • The patient must have given his/her informed and signed consent

  • The patient must be insured or beneficiary of a health insurance plan

  • painful, chronic tendinopathy (more than 3 months) of the rotator cuff, confirmed by MRI

Exclusion Criteria:
  • The patient is pregnant or breastfeeding

  • Any emergency situation

  • Non-mechanical tendinopathies (metabolic, neurological, capsulitis, reflex sympathetic dystrophy) and tendon surgery (tendon surgery and acromioplasty)

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU de Montpellier - Hôpital Lapeyronie Montpellier France 34295
2 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9 France 30029

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Nīmes

Investigators

  • Study Director: Dominique Richard, Centre Hospitalier Universitaire de Nîmes
  • Principal Investigator: Arnaud Dupeyron, MD PhD, Centre Hospitalier Universitaire de Nîmes

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Nīmes
ClinicalTrials.gov Identifier:
NCT01544244
Other Study ID Numbers:
  • PHRIP/2011/DR-03
  • 2011-A01168-33
First Posted:
Mar 5, 2012
Last Update Posted:
Jun 3, 2016
Last Verified:
Jun 1, 2016
Keywords provided by Centre Hospitalier Universitaire de Nīmes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 3, 2016